Literature DB >> 15028560

Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock.

Yves Le Tulzo1, Celine Pangault, Laurence Amiot, Valérie Guilloux, Olivier Tribut, Cédric Arvieux, Christophe Camus, Renée Fauchet, Rémi Thomas, Bernard Drénou.   

Abstract

Monocyte deactivation has been identified as a major factor of immunosuppression in sepsis and is associated with a loss of surface human leukocyte antigen-DR (HLA-DR) expression on circulating monocytes. Using flow cytometry, quantitative reverse transcription-polymerase chain reaction, we investigated this phenomenon in septic patients. We confirmed the early loss of monocyte HLA-DR expression in all infected patients and demonstrated that this persistent lowered expression at Day 6 correlated with severity scores, secondary infection, and death. This phenomenon occurred at a transcriptional level via a decrease in the class II transactivator A (CIITA) transcription. Furthermore, these abnormalities correlated with the high cortisol levels observed in sepsis and not with those of other putative factors such as catecholamines or interleukin-10. Finally, in vitro studies evidenced that glucocorticoids decrease HLA-DR expression at a transcriptional level via a decrease in CIITA mRNA levels, mainly by down modulating its isoforms I and III. We conclude that in human sepsis, the loss of HLA-DR expression on circulating monocytes is associated with a poor outcome. We suggest that the high endogenous cortisol level observed in septic shock may be a possible new factor involved in the loss of HLA-DR expression on monocytes via its effect on HLA-DR and CIITA transcription.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028560     DOI: 10.1164/rccm.200309-1329OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  51 in total

Review 1.  Immune therapy in sepsis: Are we ready to try again?

Authors:  Roger Davies; Kieran O'Dea; Anthony Gordon
Journal:  J Intensive Care Soc       Date:  2018-04-04

2.  Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone.

Authors:  Michael P Gustafson; Yi Lin; Kent C New; Peggy A Bulur; Brian Patrick O'Neill; Dennis A Gastineau; Allan B Dietz
Journal:  Neuro Oncol       Date:  2010-02-23       Impact factor: 12.300

3.  Is the measurement of monocytes HLA-DR expression useful in patients with sepsis?

Authors:  Thierry Fumeaux; Jérôme Pugin
Journal:  Intensive Care Med       Date:  2006-06-02       Impact factor: 17.440

Review 4.  Immunoparalysis and adverse outcomes from critical illness.

Authors:  W Joshua Frazier; Mark W Hall
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

Review 5.  Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM).

Authors:  Djillali Annane; Stephen M Pastores; Wiebke Arlt; Robert A Balk; Albertus Beishuizen; Josef Briegel; Joseph Carcillo; Mirjam Christ-Crain; Mark S Cooper; Paul E Marik; Gianfranco Umberto Meduri; Keith M Olsen; Bram Rochwerg; Sophia C Rodgers; James A Russell; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2017-09-21       Impact factor: 17.440

6.  Oxidized low-density lipoprotein, OXPAPC, corrects defects in maturation and cytokine secretion of peripheral blood dendritic cells from sepsis patients.

Authors:  Yun Tan; Jin-Xiu Li; Xu-Dong Xiang; Jian-Lei Lü
Journal:  Int J Clin Exp Med       Date:  2014-08-15

7.  Postoperative immunosuppression markers and the occurrence of sepsis in patients with benign and malignant disease.

Authors:  Tamara Alkhamis; Dubravka Ivić; Jasenka Wagner; Josip Ivić; Blaženka Dobrošević; Ivana Turina; Kristina Kralik; Jerko Barbić
Journal:  Wien Klin Wochenschr       Date:  2014-10-03       Impact factor: 1.704

8.  Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

Authors:  Stanimir Vuk-Pavlović; Peggy A Bulur; Yi Lin; Rui Qin; Carol L Szumlanski; Xinghua Zhao; Allan B Dietz
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

9.  Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation.

Authors:  Oh Yoen Kim; Antoine Monsel; Michèle Bertrand; Pierre Coriat; Jean-Marc Cavaillon; Minou Adib-Conquy
Journal:  Crit Care       Date:  2010-04-13       Impact factor: 9.097

Review 10.  Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.

Authors:  Guillaume Monneret; Fabienne Venet; Alexandre Pachot; Alain Lepape
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.